Sirolimus [clinicaltrials_resource:d9c86626dc781926cf0e379d9550313b]
Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant [clinicaltrials:NCT00002790]A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant [clinicaltrials:NCT00005113]clinicaltrials:NCT00006178CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme [clinicaltrials:NCT00016328]clinicaltrials:NCT00023244CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer [clinicaltrials:NCT00028028]CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma [clinicaltrials:NCT00033267]Study Evaluating Sirolimus (Rapamune™) in Solid Organ Transplant Recipients [clinicaltrials:NCT00037531]clinicaltrials:NCT00038948Sirolimus for Focal Segmental Glomerulosclerosis [clinicaltrials:NCT00040508]Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy [clinicaltrials:NCT00050713]clinicaltrials:NCT00060632clinicaltrials:NCT00061360clinicaltrials:NCT00061568Evaluating the Use of Thymoglobulin, Sirolimus, and Donor Bone Marrow With Kidney Transplantation Patients [clinicaltrials:NCT00062712]clinicaltrials:NCT00062751clinicaltrials:NCT00065468clinicaltrials:NCT00068302clinicaltrials:NCT00072176CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [clinicaltrials:NCT00075647]Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy [clinicaltrials:NCT00076206]clinicaltrials:NCT00076570clinicaltrials:NCT00078559Daclizumab and Sirolimus to Treat Uveitis [clinicaltrials:NCT00078689]Sirolimus as Secondary Therapy in Treating Patients With Chronic Graft-Versus-Host Disease That Did Not Respond To Prior Treatment [clinicaltrials:NCT00079183]CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00079235]Temsirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma [clinicaltrials:NCT00079456]clinicaltrials:NCT00081874Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer [clinicaltrials:NCT00083993]CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase [clinicaltrials:NCT00084916]clinicaltrials:NCT00085566clinicaltrials:NCT00086346CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia [clinicaltrials:NCT00086840]CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor [clinicaltrials:NCT00087074]RAD001 in Recurrent Endometrial Cancer Patients [clinicaltrials:NCT00087685]Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation [clinicaltrials:NCT00089037]Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED) [clinicaltrials:NCT00093080]Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma [clinicaltrials:NCT00093782]Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor [clinicaltrials:NCT00095329]clinicaltrials:NCT00096486
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Sirolimus [clinicaltrials_resource:d9c86626dc781926cf0e379d9550313b]
Bio2RDF identifier
d9c86626dc781926cf0e379d9550313b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d9c86626dc781926cf0e379d9550313b
identifier
clinicaltrials_resource:d9c86626dc781926cf0e379d9550313b
title
Sirolimus
@en
type
label
Sirolimus [clinicaltrials_resource:d9c86626dc781926cf0e379d9550313b]
@en